Jianglong Zhu

Title: Jianglong Zhu: Innovator in Glycopeptide Research

Introduction

Jianglong Zhu is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of glycopeptide research. With a total of 2 patents to his name, he has made notable advancements in the development of glycopeptide constructs and their applications in cancer research.

Latest Patents

Jianglong Zhu's latest patents include "Glycopeptide constructs and uses thereof" and "Multivalent glycopeptide constructs and uses thereof." The first patent discloses glycopeptide conjugates that comprise tumor-associated carbohydrate antigens and peptide epitopes. It also highlights certain glycopeptide conjugates that utilize cyclic peptide scaffolds to display carbohydrate antigens in a clustered fashion, demonstrating the immunogenicity of select glycopeptide conjugates. The second patent focuses on glycopeptide conjugates comprising GM2 and/or Gb5 carbohydrate determinants, along with methods for their production and application, again showcasing the immunogenicity of these conjugates.

Career Highlights

Jianglong Zhu is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to push the boundaries of cancer treatment through innovative research. His work has been instrumental in advancing the understanding of glycopeptide constructs and their potential therapeutic uses.

Collaborations

Some of Jianglong Zhu's notable coworkers include Samuel J. Danishefsky and Philip O. Livingston, who have collaborated with him on various research projects, contributing to the advancement of glycopeptide technology.

Conclusion

Jianglong Zhu's innovative work in glycopeptide research has the potential to significantly impact cancer treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.